The Common Sense Diet
New member
In a major development for 2026, the FDA has approved the Wegovy pill (oral semaglutide), making it the first oral GLP-1 specifically indicated for weight loss. While this is a breakthrough for those who dislike needles, the “pill vs. injection” choice involves significant trade-offs in lifestyle and effectiveness.
Here is how the new Wegovy pill compares to the traditional weekly injection.
Read also - Canadian Insulin: How Americans are Saving 80% on GLP-1 Medication Cost via Canadian Pharmacies